TECNIS IOL DXW225 (REF DXW225U265)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TEC SYMF TOR II OB SMPCY 26.5D CYL2.25 · Class 3 · Implant
All models of TECNIS IOL (1344)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05050474764286), received between Jan 6, 2026 and Jan 6, 2026 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Halo1
- Visual Disturbances1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryJan 6, 2026Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT AFTER THE IMPLANTATION OF THE PRELOADED TORIC INTRAOCULAR LENS (IOL) INTO THE LEFT EYE, THE PATIENT EXPERIENCED CONTRAST AND HALO ISSUES AND WAS MORE RELIANT ON READER GLASSES. THE PATIENT REPORTED THAT VISION HAD BEEN THIS WAY SINCE INITIAL SURGERY. THE ISSUE WAS FIRST IDENTIFIED DURING A POST-OPERATIVE EXAMINATION. IT IS UNKNOWN IF THERE WAS ONE OR MORE DAILY ACTIVITIES THAT THE PATIENT WAS UNABLE TO PERFORM DUE TO THIS ISSUE. THE LENS WAS SUBSEQUENTLY EXPLANTED IN A SECONDARY SURGERY AND REPLACED WITH A NON-JOHNSON AND JOHNSON IOL WITH +25.0 DIOPTER. NO UNPLANNED VITRECTOMY OCCURRED, BUT UNPLANNED SUTURES WERE REQUIRED TO PREVENT INJURY DUE TO UNSTABLE CAPSULE. THERE WAS NO PATIENT INJURY. IT IS UNKNOWN IF AN INCISION ENLARGEMENT WAS REQUIRED. THE PATIENT DID NOT REQUIRE ADDITIONAL MEDICAL ATTENTION AND NO MEDICATION OUTSIDE THE STANDARD OF CARE WAS PRESCRIBED. THE PATIENT'S PRE-OPERATIVE REFRACTION WAS 20/30-1 AND BEST SPECTACLE CORRECTED VISUAL ACUITY (BSCVA) WAS 20/30+1. THE PATIENT'S POST-OPERATIVE REFRACTION WITH THE ORIGINALLY IMPLANTED LENS WAS 20/30 AND BSCVA WAS 20/30. THE INTENDED TARGET REFRACTION WAS -0.30. THE PATIENT HAD A PRE-EXISTING CONDITIO
Patient problems: Halo; Visual Disturbances
MAUDE report 23986041 ↗
Other intraocular lens devices
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens146 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens145 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens144 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens139 reports
- TECNIS SIMPLICITY DIB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens1 recall81 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens129 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens127 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens126 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page